ESG

Minset's mCoder AI achieved state-of-the-art results on a demanding industry benchmark, signaling a new era of accurate, auditable autonomous coding.

With a major new financing round, BlueWind Medical is set to expand access to its innovative Revi® System for urgency urinary incontinence.

An ambitious challenge aims to turn Amazon biodiversity into sustainable businesses, betting that entrepreneurship is the key to the rainforest's survival.

As burnout and addiction surge among executives, doctors, and first responders, a new program offers a confidential, career-conscious path to recovery.

Many top professionals are diagnosed with ADHD, but a new analysis claims the real cause is childhood conditioning, not neurology. Is the cure a misstep?

The biopharma posts record Q1 revenue and profit, driven by its flagship DefenCath and a key acquisition, while a promising pipeline signals future growth.

OrganOx names Terumo's Naoya Iwata as new CEO, signaling a major push to expand its life-saving organ transplant technology across the globe.

A new film documents Robert Wickens' incredible return to racing, tackling the treacherous Nürburgring 24 Hours after a paralyzing crash.

Early human trial data for a new drug, UDP-003, suggests it can safely remove toxic cholesterol, a key step toward reversing arterial plaque buildup.

Fresh off its IPO, Agomab Therapeutics is presenting key data for its new IPF drug, AGMB-447, while courting investors on a multi-conference tour.

Natrol launches Ultra Sleep and Energy, partnering with Calm and Michelle Monaghan in a bold move to connect restorative rest with daytime vitality.

On May 18, competitors like Ulta and CVS join forces for National Sun Responsibly Day, an urgent call to make daily sun protection a life-saving habit.

The new Welch's Probiotic Yogofruits combines whole fruit, yogurt, and probiotics, aiming to redefine the 'better-for-you' category for families.

Atamyo's new gene therapy shows remarkable early results, potentially halting a severe, progressive muscular dystrophy that affects children.

A new report reveals a chasm between brand claims and reality, with prohibited cotton surging and consumer trust at an all-time low. Is science the only answer?

ABB unveils the world's first IE6 motor for explosive areas, promising massive energy savings, a rapid ROI, and a greener future for critical sectors.

The industrial giant unveils a new era of efficiency with advanced AI, a mobile factory, and the 'Suyuan' humanoid robot at Hannover Messe 2026.

As data centers strain Utah's grid, a new mobile CNG hub provides a stopgap, fueling the AI revolution one truckload at a time.

With strong HIFU revenue and new clinical trials, EDAP TMS's upcoming Investor Day will reveal its strategy for medtech dominance and investor confidence.

AutoCanada posts a Q1 loss amid a soft market, accelerating its U.S. dealership sale and relying on new leadership and its collision arm for recovery.